Adult Vaccines Market Share Expected to Gain US$ 23 Billion, at a 7.1% CAGR by 2025
Global Adult Vaccines Market – Insights
Vaccines aid in enhancing immunity against a particular disease. Vaccines are developed from weakened, killed or fragmented microorganisms, toxins or antibodies. Vaccines stimulate the immune system to attack disease-causing agents. Infants and children are routinely vaccinated against infectious diseases. In adult immunization, patients aged 18 years and older are vaccinated. The Centers of Disease Control & Prevention (CDC) recommends adults to periodically take up vaccination. According to the CDC, 2015, 30% of the patients from mission Healthy People 2020 opted for Shingles vaccine and were reported to be safe from preventable illness.
For more Information, Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1091
The global adult vaccines market was valued at US$ 12,806.49 million in 2017, and is expected to witness a robust CAGR of 7.1% over the forecast period (2017 – 2025).
Figure 1. Global Adult Vaccines Market in (US$ Mn), by Region, 2017
Global Adult Vaccines Market: Drivers
Increasing focus of several governments to prevent certain diseases and epidemic caused due to vaccine-preventable diseases is expected to boost growth of the global adult vaccines market. Several countries are focused on conducting national immunization programs and on spreading awareness regarding benefits of vaccination in children and adults. For instance, in 2015, the CDC, the U.S. Food and Drug Administration (FDA), and the National Institutes of Health (NIH) partnered with the U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) to support the advanced development of new and better influenza vaccines, as a part of inter-agency government effort in the U.S. Similarly, in India, government funded agencies such as Department of Biotechnology (DBT) and The Indian Council of Medical Research (ICMR) are focused on R&D of new vaccines. For instance, in 2015, the Department of Biotechnology projected a funding of US$ 2.95 million for Malaria Vaccine Initiative, to develop vaccine against Plasmodium falciparum and P. vivax.
Quick Buy – Adult Vaccines Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1091
Moreover, increasing awareness regarding use of vaccines to prevent diseases is also expected to boost growth of the global adult vaccines market. For instance, according to the CDC, 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden. Moreover, according to a study from the Society for Risk Analysis, 2016, GDP loss of a pandemic outbreak in the U.S. was recorded between US$ 34.4 billion and US$ 45.3 billion.
Global Adult Vaccines Market: Restraints
However, a large population not being vaccinated is expected to hinder growth of the global adult vaccines market. For instance, according to National Health Interview Survey conducted by the CDC in 2015, more than 4 out of 5 people did not report for Tdap vaccination in the U.S. and over one-third of the participants did not report for pneumococcal vaccination.
Global Adult Vaccines Market: Regional Analysis
North America accounted for the largest market share in the global adult vaccines market in 2016, owing to increasing government investment and promotion of immunization in the U.S. For instance, in 2015, the Centers for Medicare & Medicaid Services (CMS), in alignment with the CDC, introduced a five-year initiative named Healthy People 2020, to improve adult immunization as well as reduce the disparity rates caused majorly due to pneumonia, shingles, and influenza by working directly with physicians and provider offices, as well as with home health agencies, hospitals, beneficiaries and others under the guidance of Health Service Advisory Group (HSAG). Moreover, favorable Medicare coverage for adult vaccination and increased risk for pneumococcal disease among adults in the U.S. is also boosting growth of the adult vaccines market in North America. For instance, in 2015, National Health Interview Survey (NHIS) reported 2.8% increase in risk of pneumococcal disease among adults aged 19-64 years.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/adult-vaccines-market-to-surpass-beyond-us-23-billion-by-2025-505
Increasing R&D of new vaccines is boosting growth of the market in Asia Pacific. For instance, in January 2018, Bharat Biotech, an India -based company, was awarded with prequalification from the WHO to develop world’s first rotavirus vaccine, ROTAVAC.
Global Adult Vaccines Market: Competitive Landscape
Major players in the market are focused on R&D of vaccines to expand their product portfolio. For instance, in February 2017, an India-based drug firm, Cipla, in collaboration with Serum Institute of India, introduced Hepatitis B vaccine for adults in India. According to India’s Universal Immunization Program, Hepatitis B affects over 40 million people in India. Moreover, in 2018, Dynavax Technologies Corporation received FDA approval for its two-dosed Hepatitis-B vaccine indicated for adults aged 18 years and older.
Major players operating in the global adult vaccines market include Pfizer, Inc., CSL Limited, Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Serum Institute of India, Medimmune, and AstraZeneca Plc.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine
- Market Snippet, By Vaccine Type
- Market Snippet, By Technology
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Key Highlights
- Market Trends
- PEST Analysis
- Government & Non-Government Initiatives
- Epidemiology
- Market Dynamics
- Global Adult Vaccines Market, By Vaccine, 2015 – 2025, (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2016 – 2025
- Segment Trends
- Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Varicella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Human Papillomavirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Zoster
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Measles, Mumps, Rubella (MMR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Pneumococcal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Introduction
- Global Adult Vaccines Market, By Vaccine Type, 2015 – 2025, (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2016 – 2025
- Segment Trends
- Monovalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Multivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Introduction
- Global Adult Vaccines Market, By Technology, 2015 – 2025, (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, 2016 – 2025
- Segment Trends
- Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Inactivated Viral/Bacterial Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Introduction
- Global Adult Vaccines Market, By Region, 2017 – 2025, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2017 and 2025 (%)
- Y-o-Y Growth Analysis, For Region, 2016 – 2025
- North America
- Market Size and Forecast, By Vaccine, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Vaccine, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Vaccine, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Vaccine, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Vaccine, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Vaccine, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Technology, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
- Section
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
